Discovery of a potential first-in-class inhibitor targeting ADAR1 p150 isoform with strong anti-tumor efficacy in syngeneic melanoma mouse model

AVA-ADR-001 - Avammune

https://dx.doi.org/10.1136/jitc-2024-SITC2024.0740

Avijit Goswami1; Sandeep Goyal2; Kawaljit Singh3; Princy Khurana3; Aditya Kulkarni3

Oct 4, 2024